EUR 9.85
(0.15%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 41.78 Billion | 43.83 Billion | 54.5 Billion | 39.54 Billion | - |
Cost of Revenue | 24.08 Billion | 24.02 Billion | 21.72 Billion | 17.56 Billion | - |
Gross Profit | 17.69 Billion | 19.81 Billion | 32.77 Billion | 21.98 Billion | - |
Operating Expenses | 1.83 Billion | 2.02 Billion | 1.93 Billion | 2.39 Billion | -89 Million |
Selling, General and Administrative Expenses | 506 Million | 474 Million | 439 Million | 442 Million | - |
Research and Development Expenses | 723 Million | 660 Million | 549 Million | 415 Million | - |
Other Expenses | 609 Million | - | - | -115 Million | -89 Million |
Cost and Expenses | 25.92 Billion | 26.05 Billion | 23.66 Billion | 19.95 Billion | -89 Million |
Operating Income | 14.2 Billion | 17.2 Billion | 27.69 Billion | 12.82 Billion | 89 Million |
Interest Expense | 1.33 Billion | 945 Million | 1.55 Billion | 2.24 Billion | 2.5 Billion |
Income Tax Expense | 3.04 Billion | 2.97 Billion | 4.69 Billion | 735 Million | - |
Earnings before Tax | 11.15 Billion | 19.78 Billion | 29.54 Billion | 6.99 Billion | - |
Net Income | 7.98 Billion | 18.78 Million | 22.44 Million | 4.88 Million | - |
Earnings Per Share Basic | 1.83 | 4.05 | 4.48 | 0.95 | - |
Earnings Per Share Diluted | 1.83 | 4.05 | 4.47 | 0.95 | - |
Weighted Average Shares Outstanding | 4.36 Billion | 4.63 Million | 5.01 Million | 5.12 Million | 5.12 Million |
Weighted Average Shares Outstanding (Diluted) | 4.36 Billion | 4.64 Million | 5.01 Million | 5.12 Million | 5.12 Million |
Gross Margin | 0.42 | 0.45 | 0.60 | 0.56 | - |
EBIT Margin | 0.42 | 0.51 | 0.60 | 0.53 | - |
Profit Margin | 0.19 | 0.00 | 0.00 | 0.00 | - |
EBITDA | 17.64 Billion | 22.24 Billion | 34.12 Billion | 20.95 Billion | 5.83 Billion |
Earnings Before Tax Margin | 0.34 | 0.39 | 0.51 | 0.32 | - |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | 9.55 Billion | 9.92 Billion | 8.45 Billion | 41.78 Billion | 13.05 Billion | 10.62 Billion |
Cost of Revenue | 6.28 Billion | 6.34 Billion | 5.36 Billion | 24.08 Billion | 6.89 Billion | 6.3 Billion |
Gross Profit | 3.27 Billion | 3.57 Billion | 3.09 Billion | 17.69 Billion | 6.16 Billion | 4.31 Billion |
Operating Expenses | 575 Million | 583 Million | 644 Million | 1.83 Billion | 327 Million | 581 Million |
Selling, General and Administrative Expenses | 125 Million | 128 Million | 140 Million | - | 136 Million | 138 Million |
Research and Development Expenses | 192 Million | 189 Million | 156 Million | - | 231 Million | 188 Million |
Other Expenses | 258 Million | -708.89 Million | - | - | - | - |
Cost and Expenses | 6.85 Billion | 6.93 Billion | 6.01 Billion | 25.92 Billion | 7.21 Billion | 6.89 Billion |
Operating Income | 3.67 Billion | 3.87 Billion | 2.44 Billion | 14.2 Billion | 5.17 Billion | 3.27 Billion |
Interest Expense | 322 Million | 525 Million | 339 Million | 1.33 Billion | 639 Million | 239 Million |
Income Tax Expense | 336 Million | -34 Million | 448 Million | 3.04 Billion | 709 Million | 127 Million |
Earnings before Tax | 2.72 Billion | 2.73 Billion | 2.13 Billion | 11.15 Billion | 3.15 Billion | 2.98 Billion |
Net Income | 2.41 Billion | 2.76 Billion | 1.67 Million | 7.98 Million | 2.41 Million | 2.83 Million |
Earnings Per Share Basic | 563.51 | 646.91 | 0.39 | - | 0.56 | 0.66 |
Earnings Per Share Diluted | 563.51 | 646.91 | 0.39 | - | 0.56 | 0.66 |
Weighted Average Shares Outstanding | 4.28 Million | 4.28 Million | 4.28 Million | 4.36 Million | 4.31 Million | 4.31 Million |
Weighted Average Shares Outstanding (Diluted) | 4.28 Million | 4.28 Million | 4.28 Million | 4.36 Million | 4.31 Million | 4.31 Million |
Gross Margin | 0.34 | 0.36 | 0.37 | 0.42 | 0.47 | 0.41 |
EBIT Margin | 0.40 | 0.31 | 0.29 | - | 0.41 | 0.43 |
Profit Margin | 0.25 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | 3.79 Billion | 3.03 Billion | 2.47 Billion | - | 5.35 Billion | 4.53 Billion |
Earnings Before Tax Margin | 0.38 | 0.39 | 0.29 | 0.34 | 0.40 | 0.31 |
0837
BNBR
NYUKF
ENX
SKC
MRZLF